Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia.

MLA

Keating, Shelley E., et al. “Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia.” Sports Medicine, vol. 53, no. 12, Dec. 2023, pp. 2347–71. EBSCOhost, https://doi.org/10.1007/s40279-023-01918-w.

APA

Keating, S. E., Sabag, A., Hallsworth, K., Hickman, I. J., Macdonald, G. A., Stine, J. G., George, J., & Johnson, N. A. (2023). Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Medicine, 53(12), 2347–2371. https://doi.org/10.1007/s40279-023-01918-w

Chicago

Keating, Shelley E., Angelo Sabag, Kate Hallsworth, Ingrid J. Hickman, Graeme A. Macdonald, Jonathan G. Stine, Jacob George, and Nathan A. Johnson. 2023. “Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia.” Sports Medicine 53 (12): 2347–71. doi:10.1007/s40279-023-01918-w.